A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects
Status:
Completed
Trial end date:
2016-10-20
Target enrollment:
Participant gender:
Summary
This is a study designed to ascertain the effect of PF-04447943 on QT interval in healthy
adult subjects. This is conducted as part of standard drug development.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination